Safe use of proton pump inhibitors in patients with cirrhosis

AIMS: Proton pump inhibitors (PPIs) belong to the most frequently used drugs, also in patients with cirrhosis. PPIs are extensively metabolized by the liver, but practice guidance on prescribing in cirrhosis is lacking. We aim to develop practical guidance on the safe use of PPIs in patients with ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Weersink, Rianne A., Bouma, Margriet, Burger, David M., Drenth, Joost P.H., Harkes‐Idzinga, S. Froukje, Hunfeld, Nicole G.M., Metselaar, Herold J., Monster‐Simons, Margje H., van Putten, Sandra A.W., Taxis, Katja, Borgsteede, Sander D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046475/
https://www.ncbi.nlm.nih.gov/pubmed/29688583
http://dx.doi.org/10.1111/bcp.13615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046475/
https://www.ncbi.nlm.nih.gov/pubmed/29688583
http://dx.doi.org/10.1111/bcp.13615

Ejemplares similares